DAVID ADAMS: Open Payments
NPI 1366094195 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 39 payments from 18 companies in 2025. Trend: 2023 $821 · 2024 $829 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| ABBVIE INC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Novo Nordisk Inc | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $30 |
Products named: LEQVIO, Kerendia, CAPLYTA, UBRELVY, DUPIXENT, TRELEGY ELLIPTA, SPRAVATO, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
